/AWKNF
AWKNF Stock - Awakn Life Sciences Corp.
Healthcare|BiotechnologyOTC
$0.07+0.00%
+$0.00 (+0.00%) • May 27
47
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.36
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.16
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.07
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AWKNF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.06 – $0.07
TARGET (TP)$0.07
STOP LOSS$0.06
RISK/REWARD1:1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.60
52W High$0.13
52W Low$0.05
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| Revenue | $87,373 | $1.50M | $236,037 | N/A |
| Gross Profit | $87,373 | $891,809 | $-276,833 | N/A |
| Gross Margin | 100.0% | 59.6% | -117.3% | N/A |
| Operating Income | $-3,926,493 | $-9,191,720 | $-9,793,970 | $-840,301 |
| Net Income | $-5,102,704 | $-9,142,555 | $-15,945,845 | $-1,259,898 |
| Net Margin | -5840.1% | -611.4% | -6755.7% | N/A |
| EPS | $-0.13 | $-0.36 | $-0.73 | $-0.10 |
Company Overview
Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company is headquartered in Toronto, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
AWKNFBeat Rate
63%
Last 8 quarters
Avg Surprise
+13.2%
EPS vs Estimate
Beats / Misses
5/2
1 met exactly
Latest EPS
$-0.01
Q4 2024
EPS Surprise History
Q1 24
+12.6%
$-0.02vs$-0.02
Q1 24
No data
Q2 24
No data
Q2 24
+54.5%
$-0.01vs$-0.02
Q3 24
No data
Q3 24
No data
Q4 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Oct 31, 2024 | — | $-0.01 | — | — |
Q4 2024 | Oct 31, 2024 | — | $-0.01 | — | — |
Q3 2024 | Jul 31, 2024 | — | $-0.01 | — | — |
Q3 2024 | Jul 31, 2024 | — | $-0.01 | — | — |
Q2 2024 | Apr 29, 2024 | $-0.02 | $-0.01 | +54.5% | ✓ BEAT |
Q2 2024 | Apr 29, 2024 | — | $-0.01 | — | — |
Q1 2024 | Jan 30, 2024 | — | $-0.02 | — | — |
Q1 2024 | Jan 30, 2024 | $-0.02 | $-0.02 | +12.6% | ✓ BEAT |
Q4 2023 | Oct 31, 2023 | $-0.02 | $-0.02 | +28.7% | ✓ BEAT |
Q3 2023 | Jul 31, 2023 | $-0.03 | $-0.05 | -50.4% | ✗ MISS |
Q2 2023 | Apr 30, 2023 | $-0.04 | $-0.05 | -25.0% | ✗ MISS |
Q1 2023 | Jan 31, 2023 | — | $-0.07 | — | — |
Q4 2022 | Dec 15, 2022 | $-0.10 | $-0.05 | +50.0% | ✓ BEAT |
Q3 2022 | Sep 14, 2022 | $-0.09 | $-0.09 | 0.0% | = MET |
Q2 2022 | Jun 14, 2022 | $-0.17 | $-0.11 | +35.3% | ✓ BEAT |
Q1 2022 | Jan 31, 2022 | — | $-0.13 | — | — |
Q4 2021 | Dec 15, 2021 | — | $-0.10 | — | — |
Q3 2021 | Sep 14, 2021 | — | $-0.26 | — | — |
Q2 2021 | Apr 30, 2021 | — | $-0.04 | — | — |
Q1 2021 | Jan 31, 2021 | — | $-0.03 | — | — |
Latest News
Loading news...
Frequently Asked Questions about AWKNF
What is AWKNF's current stock price?
Awakn Life Sciences Corp. (AWKNF) is currently trading at $0.07 per share. The stock has moved +0.00% today.
What is the analyst price target for AWKNF?
No analyst price targets are currently available for this stock.
What sector is Awakn Life Sciences Corp. in?
Awakn Life Sciences Corp. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is AWKNF's market cap?
Awakn Life Sciences Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does AWKNF pay dividends?
No, Awakn Life Sciences Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorATIP
ATI Physical Therapy, Inc.
$0.68
Mkt Cap: $0.0B
BRRGF
BerGenBio ASA
$0.97
Mkt Cap: $0.1B
CIMVF
Pideka Group Inc.
$0.01
Mkt Cap: $0.0B
DLTNF
Delta 9 Cannabis Inc.
$0.01
Mkt Cap: $0.0B
EEVVF
Eve & Co Incorporated
$0.08
Mkt Cap: $0.0B
EPWCF
Empower Clinics Inc.
$0.00
Mkt Cap: $0.0B
FTHWF
Field Trip Health & Wellness Ltd.
$0.04
Mkt Cap: $0.0B
GABLF
GABY Inc.
$0.00
Mkt Cap: $0.0B
OCTHF
Oxford Cannabinoid Technologies Holdings Plc
$0.00
Mkt Cap: $0.0B
RVLWF
Revitalist Lifestyle and Wellness Ltd.
$0.04
Mkt Cap: $0.0B
Explore stocks similar to AWKNF for comparison